These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8092117)

  • 1. Neuron-specific enolase as a tumor marker in metastatic melanoma.
    Buzaid AC; Sandler AB; Hayden CL; Scinto J; Poo WJ; Clark MB; Hotchkiss S
    Am J Clin Oncol; 1994 Oct; 17(5):430-1. PubMed ID: 8092117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuron-specific enolase as a prognostic factor in metastatic malignant melanoma.
    Wibe E; Hannisdal E; Paus E; Aamdal S
    Eur J Cancer; 1992; 28A(10):1692-5. PubMed ID: 1389487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuron specific enolase (NSE) in serum of patients with malignant melanoma.
    Wibe E; Paus E; Aamdal S
    Cancer Lett; 1990 Jun; 52(1):29-31. PubMed ID: 2354416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. S-100 and NSE as serum markers in melanoma.
    Tofani A; Cioffi RP; Sciuto R; Rea S; Festa A; Di Filippo F; Cavaliere R; Maini CL
    Acta Oncol; 1997; 36(7):761-4. PubMed ID: 9490097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neuron-specific enolase: a serum marker of clinical progression for metastatic malignant melanoma].
    Guo HB; Stoffel-Wagner B; Brennemann W; Springer W; Klingmüller D
    J Tongji Med Univ; 1995; 15(1):19-25. PubMed ID: 7783258
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical significance of serum S100 in metastatic malignant melanoma.
    Guo HB; Stoffel-Wagner B; Bierwirth T; Mezger J; Klingmüller D
    Eur J Cancer; 1995 Oct; 31A(11):1898-902. PubMed ID: 8541129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuron-specific enolase: a serum tumor marker in renal cell carcinoma?
    Gross AJ; Michl UH; Bornhöft G; Dieckmann KP
    Eur Urol; 1993; 24(3):397-9. PubMed ID: 8262110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuron-specific enolase--a serum tumour marker in seminoma?
    Fosså SD; Klepp O; Paus E
    Br J Cancer; 1992 Feb; 65(2):297-9. PubMed ID: 1739633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neuron-specific enolase and beta 2-microglobulin in the serum of patients with melanoma].
    Uerlich M; Biltz H; Kreysel HW
    Immun Infekt; 1988 Apr; 16(2):65-7. PubMed ID: 3292403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuron-Specific Enolase as a Biomarker: Biochemical and Clinical Aspects.
    Isgrò MA; Bottoni P; Scatena R
    Adv Exp Med Biol; 2015; 867():125-43. PubMed ID: 26530364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum neuron-specific enolase and lactate dehydrogenase as predictors of response to chemotherapy and survival in non-small cell lung cancer.
    van Zandwijk N; Jassem E; Bonfrer JM; Mooi WJ; van Tinteren H
    Semin Oncol; 1992 Feb; 19(1 Suppl 2):37-43. PubMed ID: 1329221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurone specific enolase (NSE) in small cell lung cancer: a tumour marker of prognostic significance?
    Harding M; McAllister J; Hulks G; Vernon D; Monie R; Paul J; Kaye SB
    Br J Cancer; 1990 Apr; 61(4):605-7. PubMed ID: 2158809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neuron-specific enolase (NSE)--a suitable tumor marker in malignant melanoma?].
    Hornef S; Lux J; Rassner G
    Hautarzt; 1992 Feb; 43(2):77-80. PubMed ID: 1347764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pretreatment serum level of neuron specific enolase (NSE) as a prognostic factor in metastatic prostate cancer patients treated with endocrine therapy.
    Kamiya N; Akakura K; Suzuki H; Isshiki S; Komiya A; Ueda T; Ito H
    Eur Urol; 2003 Sep; 44(3):309-14; discussion 314. PubMed ID: 12932928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum neuron-specific enolase is a useful tumor marker for small cell lung cancer.
    Burghuber OC; Worofka B; Schernthaner G; Vetter N; Neumann M; Dudczak R; Kuzmits R
    Cancer; 1990 Mar; 65(6):1386-90. PubMed ID: 2155054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum neuron-specific enolase in children with neuroblastoma. Relationship to stage and disease course.
    Zeltzer PM; Marangos PJ; Evans AE; Schneider SL
    Cancer; 1986 Mar; 57(6):1230-4. PubMed ID: 3002599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuron-specific enolase as a follow-up marker in small cell bronchial carcinoma. A prospective study in an unselected series.
    Nõu E; Steinholtz L; Bergh J; Nilsson K; Påhlman S
    Cancer; 1990 Mar; 65(6):1380-5. PubMed ID: 2155053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromogranin A and neurone-specific enolase variations during the first 3 months of abiraterone therapy predict outcomes in patients with metastatic castration-resistant prostate cancer.
    Fan L; Wang Y; Chi C; Pan J; Xun S; Xin Z; Hu J; Zhou L; Dong B; Xue W
    BJU Int; 2017 Aug; 120(2):226-232. PubMed ID: 28107595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuron-specific enolase as serum marker for malignant melanoma.
    Couvreur R; Joos G; Geerts ML; Lambert J; Naeyaert JM
    Lancet; 1993 Oct; 342(8877):985. PubMed ID: 8105228
    [No Abstract]   [Full Text] [Related]  

  • 20. Correlation between lipid-associated sialic acid and tumor burden in melanoma.
    Buzaid AC; Sandler AB; Hayden CL; Scinto J; Poo WJ; Clark MB; Hotchkiss S
    Int J Biol Markers; 1994; 9(4):247-50. PubMed ID: 7836804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.